The clinical trial process needs a refresh. The antiquated system is ripe for innovation, but it?s not been an easy road to change. Diversity in clinical research and trials is still a persistent issue. We are not representative of all patients, leading to a massive problem down the road when the treatment is ultimately approved and yet not efficacious in all who can benefit. Decentralizing the process is making inroads, but more progress is needed to have a system free of disparities. What have we been doing wrong this whole time? Experts from all parts of the health industry will lead the way to a better system, so let?s hear them out.